Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$138K Hold
986
0.03% 140
2022
Q3
$127K Hold
986
0.03% 154
2022
Q2
$139K Hold
986
0.03% 138
2022
Q1
$137K Hold
986
0.02% 154
2021
Q4
$172K Hold
986
0.03% 144
2021
Q3
$163K Hold
986
0.02% 138
2021
Q2
$177K Hold
986
0.03% 144
2021
Q1
$190K Sell
986
-155
-14% -$29.8K 0.03% 131
2020
Q4
$230K Buy
1,141
+1
+0.1% +$207 0.04% 123
2020
Q3
$249K Hold
1,140
0.05% 121
2020
Q2
$271K Buy
1,140
+53
+5% +$10.6K 0.06% 110
2020
Q1
$222K Buy
+1,087
New +$180K 0.06% 109

Other funds holding CLX

Burleson & Co's CLX Position: Q4 2022 in Review

Burleson & Co held its Clorox (CLX) position steady in Q4 2022 at 986 shares worth $138K. The position accounts for 0.03% of the portfolio, ranked #140.

Burleson & Co first reported a position in CLX in Q1 2020 and has held it in 12 quarters since. The position peaked at $271K in Q2 2020. 1,108 funds tracked by Wall St. Rank hold CLX as of Q4 2022.

  • Burleson & Co held 986 shares of Clorox worth $138K as of Q4 2022.
  • Burleson & Co left its Clorox share count unchanged in Q4 2022.
  • Clorox made up 0.03% of Burleson & Co's portfolio in Q4 2022, its #140 holding.
  • Burleson & Co first reported a position in Clorox in Q1 2020 and has held it in 12 quarters since.
  • Burleson & Co's Clorox position peaked at $271K in Q2 2020.
  • 1,108 funds tracked by Wall St. Rank held Clorox as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.